Trial Details

COMPLETED
Basic Information
Clinical ID c1827
Identifier NCT03473626
Trial Title Phase 1 Food Effect Study for Alicaforsen Tablets
Trial URL Visit Original Page
Study Information
Study Results

NO

Conditions IBD
Interventions DRUG: Alicaforsen
Participant Information
Sponsor Atlantic Pharmaceuticals Ltd
City Nottingham
Country/Region United Kingdom
Enrollment Criteria
Sex Requirement MALE
Age Requirement -
Study Design
Study Type INTERVENTIONAL
Phase PHASE1
Time Information
Start Date 2018-03-16
Primary Completion Date 2018-04-06
Completion Date 2018-04-06